Infant group B streptococcal disease incidence and serotypes worldwide: systematic review and meta-analyses
L Madrid, AC Seale, M Kohli-Lynch… - Clinical infectious …, 2017 - academic.oup.com
Abstract Background Group B Streptococcus (GBS) remains a leading cause of neonatal
sepsis in high-income contexts, despite declines due to intrapartum antibiotic prophylaxis …
sepsis in high-income contexts, despite declines due to intrapartum antibiotic prophylaxis …
Risk of early-onset neonatal group B streptococcal disease with maternal colonization worldwide: systematic review and meta-analyses
NJ Russell, AC Seale, C O'Sullivan… - Clinical infectious …, 2017 - academic.oup.com
Background Early-onset group B streptococcal disease (EOGBS) occurs in neonates (days 0–
6) born to pregnant women who are rectovaginally colonized with group B Streptococcus …
6) born to pregnant women who are rectovaginally colonized with group B Streptococcus …
Causes and incidence of community-acquired serious infections among young children in south Asia (ANISA): an observational cohort study
SK Saha, SJ Schrag, S El Arifeen, LC Mullany… - The Lancet, 2018 - thelancet.com
Background More than 500 000 neonatal deaths per year result from possible serious
bacterial infections (pSBIs), but the causes are largely unknown. We investigated the …
bacterial infections (pSBIs), but the causes are largely unknown. We investigated the …
Pattern of infectious morbidity in HIV-exposed uninfected infants and children
Background Almost 30% of children in Southern Africa are HIV exposed but uninfected
(HEU) and experience exposures that could increase vulnerability to infectious diseases …
(HEU) and experience exposures that could increase vulnerability to infectious diseases …
Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in healthy women and their infants: a randomised phase 1b/2 trial
SA Madhi, CL Cutland, L Jose, A Koen… - The Lancet infectious …, 2016 - thelancet.com
Background Maternal group B streptococcus (GBS) serotype-specific capsular antibody
concentrations are correlated with susceptibility to neonatal GBS invasive disease. Maternal …
concentrations are correlated with susceptibility to neonatal GBS invasive disease. Maternal …
[HTML][HTML] WHO consultation on group B Streptococcus vaccine development: report from a meeting held on 27–28 April 2016
M Kobayashi, SJ Schrag, MR Alderson, SA Madhi… - Vaccine, 2019 - Elsevier
Abstract Globally, group B Streptococcus (GBS) remains a leading cause of sepsis and
meningitis in infants in the first 90 days of life. Intrapartum antibiotic prophylaxis (IAP) for …
meningitis in infants in the first 90 days of life. Intrapartum antibiotic prophylaxis (IAP) for …
Group B streptococcus vaccination in pregnant women with or without HIV in Africa: a non-randomised phase 2, open-label, multicentre trial
Background Neonates born to women infected with HIV are at increased risk for invasive
group B streptococcus (GBS) disease. We aimed to compare safety and immunogenicity of …
group B streptococcus (GBS) disease. We aimed to compare safety and immunogenicity of …
Maternal colonization with Streptococcus agalactiae and associated stillbirth and neonatal disease in coastal Kenya
AC Seale, AC Koech, AE Sheppard, HC Barsosio… - Nature …, 2016 - nature.com
Streptococcus agalactiae (group B streptococcus, GBS) causes neonatal disease and
stillbirth, but its burden in sub-Saharan Africa is uncertain. We assessed maternal recto …
stillbirth, but its burden in sub-Saharan Africa is uncertain. We assessed maternal recto …
Group B streptococcus and respiratory syncytial virus immunisation during pregnancy: a landscape analysis
Group B streptococcus and respiratory syncytial virus are leading causes of infant morbidity
and mortality worldwide. No licensed vaccines are available for either disease, but vaccines …
and mortality worldwide. No licensed vaccines are available for either disease, but vaccines …
[HTML][HTML] Group B Streptococcus vaccine development: present status and future considerations, with emphasis on perspectives for low and middle income countries
M Kobayashi, J Vekemans, CJ Baker, AJ Ratner… - …, 2016 - ncbi.nlm.nih.gov
Abstract Globally, group B Streptococcus (GBS) remains the leading cause of sepsis and
meningitis in young infants, with its greatest burden in the first 90 days of life. Intrapartum …
meningitis in young infants, with its greatest burden in the first 90 days of life. Intrapartum …